Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I

European Journal of Endocrinology

Volumn 152, Issue 5, 2005, Pages 719-726

  Christiansen, Jens Juel ^d   Fisker, Sanne ^d   Gravholt, Claus Højbjerg ^d   Bennett, Paul ^a   Svenstrup, Birgit ^a   Andersen, Marianne ^b   Feldt Rasmussen, Ulla ^c   Christiansen, Jens Sandahl ^d   Jørgensen, Jens Otto Lunde ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; CORTICOTROPIN; DESMOPRESSIN; ESTROGEN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN;

ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN DEFICIENCY; DIABETES INSIPIDUS; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPITUITARISM; HYPOTHYROIDISM; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

ADULT; BODY COMPOSITION; DEHYDROEPIANDROSTERONE SULFATE; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 19744377664     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01898     Document Type: Article

References (24)

1. Jorgensen JO, Vahl N, Hansen TB, Skjaerbaek C, Fisker S, Orskov H, Hagen C & Christiansen JS. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared with healthy subjects. Clinical Endocrinology 1998 48 479-486.
2. Fisker S, Jorgensen JO, Vahl N, Orskov H & Christiansen JS. Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults. European Journal of Endocrinology 1999 141 601-608.
3. Burman P, Johansson AG, Siegbahn A, Vessby B & Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women [see comments]. Journal of Clinical Endocrinology and Metabolism 1997 82 550-555.
4. Weissberger AJ, Ho KK & Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-h growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1991 72 374-381.
5. Holloway L, Butterfield G, Hintz RL, Gesundheit N & Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. Journal of Clinical Endocrinology and Metabolism 1994 79 470-479.
6. Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H & Christiansen JS. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. American Journal of Physiology 1997 272 E1108-E1116.
7. Hobbs CJ, Plymate SR, Rosen CJ & Adler RA. Testosterone administration increases insulin-like growth factor-I levels in normal men. Journal of Clinical Endocrinology and Metabolism 1993 77 776-779.
8. Liu L, Merriam GR & Sherins RJ. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 1987 64 651-656.
9. Lukaski HC, Johnson PE, Bolonchuk WW & Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. American Journal of Clinical Nutrition 1985 41 810-817.
10. Lykkesfeldt G, Bennett P, Lykkesfeldt AE, Micic S, Moller S & Svenstrup B. Abnormal androgen and oestrogen metabolism in men with steroid sulphatase deficiency and recessive X-linked ichthyosis. Clinical Endocrinology 1985 23 385-393.
11. Bartsch W. Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas 1980 2 109-118.
12. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
13. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C & Ho KK. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clinical Endocrinology 1993 39 561-567.
14. O'Sullivan AJ, Crampton LJ, Freund J & Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. Journal of Clinical Investigation 1998 102 1035-1040.
15. Dawson-Hughes B, Stern D, Goldman J & Reichlin S. Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. Journal of Clinical Endocrinology and Metabolism 1986 63 424-432.
16. Friend KE, Hartman ML, Pezzoli SS, Clasey JL & Thorner MO. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 81 2250-2256.
17. Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S & Klibanski A. Androgen deficiency in women with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 2001 86 561-567.
18. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA & Karlsson FA. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2002 87 2046-2052.
19. Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 1974 39 340-346.
20. Piltonen T, Koivunen R, Morin-Papunen L, Ruokonen A, Huhtaniemi IT & Tapanainen JS. Ovarian and adrenal steroid production: regulatory role of LH/HCG. Human Reproduction 2002 17 620.
21. Abraham GE, Chakmakjian ZH, Buster JE & Marshall JR. Effect of exogenous conjugated estrogen on plasma gonadotropins and ovarian steroids during the menstrual cycle. Obstetrics and Gynecology 1974 43 676-684.
22. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rosen T, Thoren M & Bengtsson BA. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology & Metabolism 1996 81 1575-1581.
23. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CKW, Low TH, Leong GM, Ross RJM & Ho KKY. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. PNAS 2003 100 1016-1021.
24. Fournier B, Gutzwiller S, Dittmar T, Matthias G, Steenbergh P & Matthias P. Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by antiestrogens. Journal of Biological Chemistry 2001 276 35444-35449.